According to a news release from UW Health spokesperson Emily Kumlien, UW has supplies of the two new oral antiviral pills, Pfizer’s Paxlovid and Merck’s molnupiravir, to treat a total of 40 people. UW Health hospitalist Dr. Bartho Caponi said the short supply will keep new treatments restricted to people in the most need.
University Communications